gerresheimer ag - GRRMF

GRRMF

Close Chg Chg %
51.41 -14.58 -28.36%

Closed Market

36.83

-14.58 (28.36%)

Volume: 200.00

Last Updated:

Oct 9, 2025, 9:38 AM EDT

Company Overview: gerresheimer ag - GRRMF

GRRMF Key Data

Open

$36.83

Day Range

36.83 - 36.83

52 Week Range

36.83 - 91.72

Market Cap

$1.12B

Shares Outstanding

34.54M

Public Float

31.52M

Beta

0.84

Rev. Per Employee

N/A

P/E Ratio

43.70

EPS

$0.74

Yield

13.39%

Dividend

$0.05

EX-DIVIDEND DATE

Jun 6, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

26.22

 

GRRMF Performance

No Data Available

GRRMF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About gerresheimer ag - GRRMF

Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. It operates through the following segments: Plastic and Devices, Primary Packaging Glass, and Advanced Technologies. The Plastic and Devices segment includes insulin pens, inhalers and refillable syringes as well as diagnostics and medical technology products such as skin-prick aids and test systems and pharmaceutical plastic containers for liquid and solid medicines. The Primary Packaging Glass segment refers to the primary packaging made of glass of medicines and cosmetics such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, and special containers for food and drinks. The Advanced Technologies segment focuses on the technical and digital solutions to improve patient treatment outcomes. The company was founded in 1864 and is headquartered in Duesseldorf, Germany.

GRRMF At a Glance

Gerresheimer AG
Klaus-Bungert-Strasse 4
Dusseldorf, Nordrhein-Westfalen 40468
Phone 49-211-6181-00 Revenue 2.21B
Industry Containers/Packaging Net Income 119.08M
Sector Process Industries 2024 Sales Growth 2.931%
Fiscal Year-end 11 / 2025 Employees 12,142
View SEC Filings

GRRMF Valuation

P/E Current 43.695
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 22.884
Price to Sales Ratio 1.233
Price to Book Ratio 1.707
Price to Cash Flow Ratio 10.43
Enterprise Value to EBITDA 9.05
Enterprise Value to Sales 1.772
Total Debt to Enterprise Value 0.347

GRRMF Efficiency

Revenue/Employee 181,985.792
Income Per Employee 9,807.678
Receivables Turnover 5.174
Total Asset Turnover 0.56

GRRMF Liquidity

Current Ratio 1.007
Quick Ratio 0.647
Cash Ratio 0.189

GRRMF Profitability

Gross Margin 27.607
Operating Margin 9.832
Pretax Margin 7.211
Net Margin 5.389
Return on Assets 3.015
Return on Equity 7.504
Return on Total Capital 4.029
Return on Invested Capital 4.90

GRRMF Capital Structure

Total Debt to Total Equity 85.123
Total Debt to Total Capital 45.982
Total Debt to Total Assets 33.20
Long-Term Debt to Equity 60.643
Long-Term Debt to Total Capital 32.758
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Gerresheimer Ag - GRRMF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.78B 1.92B 2.15B 2.21B
Sales Growth
+11.02% +7.76% +11.78% +2.93%
Cost of Goods Sold (COGS) incl D&A
1.30B 1.39B 1.55B 1.60B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
172.05M 181.19M 197.04M 215.48M
Depreciation
114.60M 126.04M 140.22M 157.22M
Amortization of Intangibles
57.44M 55.15M 56.82M 58.26M
COGS Growth
+12.58% +6.79% +11.55% +3.02%
Gross Income
478.77M 528.54M 593.94M 610.02M
Gross Income Growth
+6.98% +10.40% +12.37% +2.71%
Gross Profit Margin
+26.86% +27.52% +27.67% +27.61%
2021 2022 2023 2024 5-year trend
SG&A Expense
309.74M 349.59M 369.45M 399.97M
Research & Development
11.90M 22.85M 17.39M 24.29M
Other SG&A
297.84M 326.74M 352.05M 375.68M
SGA Growth
+11.89% +12.86% +5.68% +8.26%
Other Operating Expense
(5.73M) (10.30M) (5.83M) (7.20M)
Unusual Expense
10.85M 17.84M 9.82M 17.68M
EBIT after Unusual Expense
163.91M 171.41M 220.50M 199.57M
Non Operating Income/Expense
12.74M 6.96M 14.46M 25.57M
Non-Operating Interest Income
1.58M 2.10M 4.10M 5.32M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
24.63M 29.55M 54.39M 65.80M
Interest Expense Growth
+4.84% +19.96% +84.10% +20.97%
Gross Interest Expense
24.63M 29.55M 54.39M 65.80M
Interest Capitalized
- - - -
-
Pretax Income
152.03M 148.82M 180.57M 159.34M
Pretax Income Growth
-0.56% -2.11% +21.33% -11.76%
Pretax Margin
+8.53% +7.75% +8.41% +7.21%
Income Tax
48.33M 40.82M 51.06M 37.44M
Income Tax - Current - Domestic
54.01M 43.59M 58.03M 45.19M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(5.68M) (2.77M) (6.97M) (7.75M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
103.79M 108.01M 129.51M 121.90M
Minority Interest Expense
4.11M 6.42M 4.27M 2.82M
Net Income
99.69M 101.59M 125.24M 119.08M
Net Income Growth
-0.52% +1.91% +23.28% -4.92%
Net Margin Growth
+5.59% +5.29% +5.83% +5.39%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
99.69M 101.59M 125.24M 119.08M
Preferred Dividends
- - - -
-
Net Income Available to Common
99.69M 101.59M 125.24M 119.08M
EPS (Basic)
3.1747 3.2354 3.757 3.4477
EPS (Basic) Growth
-0.52% +1.91% +16.12% -8.23%
Basic Shares Outstanding
31.40M 31.40M 33.34M 34.54M
EPS (Diluted)
3.1747 3.2354 3.757 3.4477
EPS (Diluted) Growth
-0.52% +1.91% +16.12% -8.23%
Diluted Shares Outstanding
31.40M 31.40M 33.34M 34.54M
EBITDA
346.81M 370.44M 427.37M 432.74M
EBITDA Growth
-0.12% +6.81% +15.37% +1.26%
EBITDA Margin
+19.46% +19.29% +19.91% +19.58%

Gerresheimer Ag in the News